Gastroenterology Practice Questions

Q: A patient presents with a distended abdomen and jaundice. Blood tests reveal elevated ammonia levels. What is the most likely cause of the hyperammonemia?

Liver failure. ***Liver failure*** - **Liver failure** impairs the liver's ability to convert ammonia to urea, leading to its accumulation in the blood [1]. - The symptoms of a **distended abdomen** (due to ascites) and **jaundice** (due to impaired bilirubin metabolism) are classic signs of advanced liver disease [2]. *Kidney failure* - **Kidney failure** primarily affects the excretion of waste products like urea and creatinine, but it is not a direct cause of **hyperammonemia**. - While severe kidney failure can cause some ammonia accumulation, it is typically secondary to impaired renal ammoniagenesis or metabolic acidosis, not the primary mechanism behind the symptoms described. *Pancreatitis* - **Pancreatitis** involves inflammation of the pancreas and typically presents with severe abdominal pain, nausea, and vomiting. - It does not directly cause **jaundice** or **hyperammonemia**, although it can be a complication of underlying conditions that might also affect the liver or bile ducts. *Heart failure* - **Heart failure** can lead to symptoms like edema and shortness of breath, but it does not directly cause **jaundice** or **hyperammonemia**. - While severe right-sided heart failure can cause **congestive hepatopathy** and mild liver dysfunction, it is rarely the primary cause of such pronounced jaundice and hyperammonemia as described.

Q: A 12-year-old boy presents with jaundice, dark urine, and pale stools. He is diagnosed with autoimmune hepatitis. Which antibody is most likely to be positive?

Anti-Smooth Muscle Antibody (ASMA). ***Anti-Smooth Muscle Antibody (ASMA)*** - **Type 1 autoimmune hepatitis** often presents in children and young adults, and is characterized by a high prevalence of **anti-smooth muscle antibodies (ASMA)** and/or **anti-nuclear antibodies (ANA)** [1]. - The presence of **jaundice**, **dark urine**, and **pale stools** in a 12-year-old boy is consistent with acute hepatitis. *Anti-Mitochondrial Antibody* - This antibody is the serological hallmark of **primary biliary cholangitis (PBC)**, an autoimmune disease primarily affecting the small bile ducts, more common in middle-aged women [2]. - It is not typically associated with classic childhood autoimmune hepatitis and would not explain the presented symptoms. *Anti-Liver/Kidney Microsomal Antibody* - This antibody (specifically **anti-LKM1**) is primarily associated with **Type 2 autoimmune hepatitis**, which often affects younger children (preschool age) and can have a more severe clinical course. - While possible, ASMA (and ANA) are most commonly found in Type 1, which has a broader age range including 12-year-olds. *Anti-Nuclear Antibody* - **Anti-nuclear antibody (ANA)** can be positive in Type 1 autoimmune hepatitis, similar to ASMA [1]. - However, ASMA is often more specific for autoimmune hepatitis particularly in patients presenting with these features, while ANA can be positive in many other autoimmune conditions [3].

Q: A 45-year-old male with chronic hepatitis B is being evaluated for antiviral therapy. His HBV DNA levels are elevated, and a liver biopsy shows moderate inflammation and fibrosis. What is the most appropriate antiviral regimen for this patient?

Tenofovir. ***Tenofovir*** - **Tenofovir** is a highly potent **nucleotide analog reverse transcriptase inhibitor** - **First-line therapy for chronic hepatitis B** due to its high barrier to resistance and potent viral suppression. *Interferon therapy* - **Interferon therapy** is an alternative, but it has significant **side effects** and is often **less preferred** for long-term treatment compared to nucleos(t)ide analogs [1]. - It involves weekly injections and can cause **flu-like symptoms**, psychiatric disturbances, and cytopenias [1]. *Lamivudine* - **Lamivudine** is a **nucleoside analog** that has a **low barrier to resistance**, meaning the virus can easily develop mutations that make the drug ineffective over time. - It is **not recommended** as a first-line agent for chronic hepatitis B due to the high risk of resistance. *Adefovir* - **Adefovir** is another **nucleotide analog** that has a **higher risk of nephrotoxicity** (kidney damage) compared to tenofovir. - It is **not a first-line treatment** option due to its less favorable safety profile and lower potency than tenofovir.

Q: A 30-year-old woman presents with abdominal pain, hepatomegaly, and Kayser-Fleischer rings. What disorder is consistent with these findings?

Wilson disease. ***Wilson disease*** - Characterized by **copper accumulation** in tissues [1], which leads to **hepatomegaly** and **Kayser-Fleischer rings** in the cornea. - Symptoms often include **abdominal pain** due to liver involvement and potential neurological effects [1]. *Hemochromatosis* - Involves **iron overload** rather than copper [2], typically leading to **diabetes**, skin pigmentation, and arthropathy. - Kayser-Fleischer rings are not present; they are specific to Wilson disease. *Non-alcoholic fatty liver disease* - Primarily related to **insulin resistance** and does not cause Kayser-Fleischer rings. - Symptoms typically include **elevated liver enzymes** rather than specific neurological or ocular manifestations. *Alpha-1 antitrypsin deficiency* - Associated with **lung disease** and sometimes liver disease but lacks Kayser-Fleischer rings and has different clinical features. - Often presents with **pulmonary symptoms** such as **emphysema** along with liver issues.

Q: A patient with a long history of alcohol use presents with abdominal pain and weight loss. A CT scan shows pancreatic calcifications. Which condition is consistent with these findings?

Chronic pancreatitis. ***Chronic pancreatitis*** - Long-term **alcohol use** can lead to pancreatic damage, causing **calcifications** in the pancreas, as seen on CT [1]. - Symptoms like **abdominal pain and weight loss** are classical signs associated with chronic pancreatic inflammation [1]. *Pancreatic pseudocyst* - Typically arises as a **complication of acute pancreatitis**, characterized by collections of fluid rather than calcifications. - Doesn't usually cause weight loss directly and is often asymptomatic unless gland dysfunction occurs. *Pancreatic adenocarcinoma* - While it may present with weight loss, it typically does not result in **pancreatic calcifications**; rather, it presents with masses on imaging. - Symptoms are usually more insidious, including **jaundice** and new-onset diabetes, not simply abdominal pain. *Acute pancreatitis* - Often associated with severe abdominal pain, but would not show calcifications prominently on imaging. - It typically presents with **edema and fluid collections**, not the chronic fibrosis and calcifications seen in chronic pancreatitis.

Q: A 45-year-old woman with a history of irritable bowel syndrome presents with chronic abdominal pain, bloating, and diarrhea. Which of the following is most likely to improve her symptoms?

Low-FODMAP diet. ***Low-FODMAP diet*** - This diet restricts **fermentable oligosaccharides, disaccharides, monosaccharides, and polyols**, which are poorly absorbed carbohydrates that can ferment in the gut, causing gas, bloating, and pain common in **irritable bowel syndrome (IBS)** [1]. - Clinical trials have shown that a **low-FODMAP diet** can significantly reduce symptoms like **abdominal pain**, **bloating**, and **diarrhea** in a substantial number of IBS patients [1]. *High-fiber diet* - While fiber is generally healthy, a **high-fiber diet** can exacerbate symptoms such as **bloating** and **gas** in some IBS patients, particularly those with IBS-D (diarrhea-predominant IBS), due to increased colonic fermentation. - The type of fiber matters; **soluble fiber** may be better tolerated than **insoluble fiber** for IBS symptoms, but increasing overall fiber can still worsen symptoms for many. *Lactose-free diet* - A **lactose-free diet** is beneficial only if the patient has **lactose intolerance**, which can mimic some IBS symptoms [2]. However, not all IBS patients are lactose intolerant, and adopting this diet won't address other dietary triggers. - While lactose intolerance can coexist with IBS, it's a specific food intolerance, and eliminating lactose alone is unlikely to alleviate the broad spectrum of IBS symptoms if other **FODMAPs** are still being consumed [2]. *Probiotics* - **Probiotics** can be helpful for some IBS patients by modulating gut microbiota and reducing inflammation, but their efficacy varies widely among individuals and specific strains. - While recommended as a potential adjunct therapy, **probiotics** are generally not considered the *most likely* single intervention to comprehensively improve all primary symptoms of IBS-D like a **low-FODMAP diet** [1].

Q: A 25-year-old male patient presents with jaundice, dark urine, and elevated liver enzymes. He tests positive for HBsAg and HBeAg. What is the most appropriate treatment?

Tenofovir. ***Tenofovir*** - This patient presents with **acute hepatitis B** (jaundice, dark urine, elevated liver enzymes, HBsAg, HBeAg), indicating active viral replication [1]. **Tenofovir** is a highly effective **nucleotide analog reverse transcriptase inhibitor** used to treat chronic HBV infection, and can be used in severe acute cases or those at risk of chronicity [1]. - It works by inhibiting the **HBV reverse transcriptase**, thereby reducing viral load and preventing liver damage. *Acyclovir* - **Acyclovir** is an antiviral medication specifically used to treat **herpes simplex virus (HSV)** and **varicella-zoster virus (VZV)** infections [3]. - It has no activity against the **hepatitis B virus (HBV)**, making it ineffective for this patient's condition [3]. *Ribavirin* - **Ribavirin** is an antiviral drug primarily used in combination with other agents, such as interferon, for the treatment of **hepatitis C virus (HCV)** infection. - It is **not effective** against the hepatitis B virus and is not indicated for the management of acute or chronic HBV. *Interferon-alpha* - **Interferon-alpha** is an immunomodulatory agent that can be used to treat both chronic **hepatitis B** and **hepatitis C** infections [2]. - However, for acute severe hepatitis B, **nucleoside/nucleotide analogs like tenofovir** are generally preferred due to better tolerability and higher antiviral efficacy in rapidly reducing viral replication [1].

Q: A 40-year-old man presents with liver disease and neurological symptoms. His serum ceruloplasmin levels are low. Which condition is most likely?

Wilson disease. ***Wilson disease*** - **Wilson disease** is characterized by impaired copper metabolism, leading to copper accumulation in the liver, brain, and other organs, causing **liver disease** and **neurological symptoms** [1]. - **Low serum ceruloplasmin** is a hallmark finding, as ceruloplasmin is the primary copper-carrying protein in the blood, and its synthesis is defective in Wilson disease [4]. *Hemochromatosis* - **Hemochromatosis** is an iron overload disorder, not copper, and would present with elevated **ferritin** and **transferrin saturation**, not low ceruloplasmin [2]. - While it can cause liver disease, it is not associated with the distinct neurological symptoms seen in Wilson disease, and ceruloplasmin levels would typically be normal [2]. *Acute intermittent porphyria* - **Acute intermittent porphyria** is a genetic disorder affecting heme synthesis, leading to neurological and psychiatric symptoms, and acute abdominal pain [3]. - It does not involve copper metabolism, and **liver disease** is not a primary feature, nor are ceruloplasmin levels affected. *Primary biliary cirrhosis* - **Primary biliary cirrhosis** (now often called primary biliary cholangitis) is an autoimmune disease causing destruction of bile ducts within the liver, leading to **cholestatic liver disease**. - While it can cause liver damage, it is typically associated with **antimitochondrial antibodies (AMA)** and does not primarily cause neurological symptoms or low ceruloplasmin levels.

Q: A 30-year-old female presents with progressive difficulty swallowing and a sensation of a lump in her throat. A barium swallow shows a filling defect in the esophagus. What is the most likely diagnosis?

Esophageal carcinoma. ***Esophageal carcinoma*** - Progressive **dysphagia** (difficulty swallowing) and a sensation of a **lump in the throat** in a 30-year-old, especially with a **filling defect on barium swallow**, raise strong suspicion for esophageal carcinoma, although less common in this age group, it must be ruled out with an endoscopy and biopsy [1]. - While other conditions can cause dysphagia, the "filling defect" points towards a **mass lesion** rather than functional or circumferential narrowing. *Esophageal stricture* - An **esophageal stricture** typically presents with progressive dysphagia, but it is a **narrowing** of the esophagus, not usually a distinct filling defect on barium swallow. - Strictures are often caused by **GERD** or caustic injury and would show as a smooth, localized narrowing. *Achalasia* - **Achalasia** is a motility disorder characterized by incomplete relaxation of the **lower esophageal sphincter** and aperistalsis of the esophageal body, leading to dysphagia for both solids and liquids [2]. - Barium swallow typically shows a **'bird's beak' appearance** due to distal esophageal narrowing but no filling defect [2]. *Esophageal web* - An **esophageal web** is a thin, usually anterior, abnormal growth of mucosa in the esophagus that causes intermittent dysphagia, particularly with solids. - It would appear as a **thin, shelf-like constriction** on a barium swallow, not a filling defect.

Q: A 45-year-old female presents with a long-standing history of heartburn and regurgitation. Endoscopy reveals Barrett's esophagus. What is the primary concern for this patient?

Esophageal cancer. ***Esophageal cancer*** - Barrett's esophagus is a precancerous condition that significantly increases the risk of **adenocarcinoma** of the esophagus [3]. - Regular surveillance is necessary due to potential **malignant transformation** in patients with Barrett's esophagus [3]. *Achalasia* - This condition presents with **dysphagia** for solids and liquids and does not show a direct link to Barrett's esophagus. - It primarily affects the **lower esophageal sphincter**, leading to **esophageal dilation** rather than a concern for cancer [1]. *Peptic stricture* - While this may occur due to chronic gastroesophageal reflux, it is not as significant a concern as **esophageal cancer** in patients with Barrett's esophagus [2]. - Peptic strictures are typically **benign** and can be treated with dilation [1]. *Gastric ulcer* - Gastric ulcers are unrelated to Barrett's esophagus and present differently, mainly with **epigastric pain**. - They do not stem from **chronic reflux** and thus are not a primary concern in this patient.

Question 1

A patient presents with a distended abdomen and jaundice. Blood tests reveal elevated ammonia levels. What is the most likely cause of the hyperammonemia?

Accepted Answer

Liver failure

Answer

Kidney failure

Answer

Pancreatitis

Answer

Heart failure

Question 2

A 12-year-old boy presents with jaundice, dark urine, and pale stools. He is diagnosed with autoimmune hepatitis. Which antibody is most likely to be positive?

Accepted Answer

Anti-Smooth Muscle Antibody (ASMA)

Answer

Anti-Mitochondrial Antibody

Answer

Anti-Liver/Kidney Microsomal Antibody

Answer

Anti-Nuclear Antibody

Question 3

A 45-year-old male with chronic hepatitis B is being evaluated for antiviral therapy. His HBV DNA levels are elevated, and a liver biopsy shows moderate inflammation and fibrosis. What is the most appropriate antiviral regimen for this patient?

Accepted Answer

Tenofovir

Answer

Interferon therapy

Answer

Lamivudine

Answer

Adefovir

Question 4

A 30-year-old woman presents with abdominal pain, hepatomegaly, and Kayser-Fleischer rings. What disorder is consistent with these findings?

Accepted Answer

Wilson disease

Answer

Hemochromatosis

Answer

Alpha-1 antitrypsin deficiency

Answer

Non-alcoholic fatty liver disease

Question 5

A patient with a long history of alcohol use presents with abdominal pain and weight loss. A CT scan shows pancreatic calcifications. Which condition is consistent with these findings?

Accepted Answer

Chronic pancreatitis

Answer

Acute pancreatitis

Answer

Pancreatic pseudocyst

Answer

Pancreatic adenocarcinoma

Question 6

A 45-year-old woman with a history of irritable bowel syndrome presents with chronic abdominal pain, bloating, and diarrhea. Which of the following is most likely to improve her symptoms?

Accepted Answer

Low-FODMAP diet

Answer

High-fiber diet

Answer

Lactose-free diet

Answer

Probiotics

Question 7

A 25-year-old male patient presents with jaundice, dark urine, and elevated liver enzymes. He tests positive for HBsAg and HBeAg. What is the most appropriate treatment?

Accepted Answer

Tenofovir

Answer

Acyclovir

Answer

Ribavirin

Answer

Interferon-alpha

Question 8

A 40-year-old man presents with liver disease and neurological symptoms. His serum ceruloplasmin levels are low. Which condition is most likely?

Accepted Answer

Wilson disease

Answer

Hemochromatosis

Answer

Acute intermittent porphyria

Answer

Primary biliary cirrhosis

Question 9

A 30-year-old female presents with progressive difficulty swallowing and a sensation of a lump in her throat. A barium swallow shows a filling defect in the esophagus. What is the most likely diagnosis?

Accepted Answer

Esophageal carcinoma

Answer

Esophageal stricture

Answer

Achalasia

Answer

Esophageal web

Question 10

A 45-year-old female presents with a long-standing history of heartburn and regurgitation. Endoscopy reveals Barrett's esophagus. What is the primary concern for this patient?

Accepted Answer

Esophageal cancer

Answer

Gastric ulcer

Answer

Peptic stricture

Answer

Achalasia

Gastroenterology — MCQs

Gastroenterology — MCQs

On this page

Practice by Chapter

Want unlimited practice?